Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial.
Nkosi-Gondwe T, Robberstad B, Mukaka M, Idro R, Opoka RO, Banda S, Kühl MJ, O Ter Kuile F, Blomberg B, Phiri KS. Nkosi-Gondwe T, et al. PLoS One. 2021 Sep 10;16(9):e0255769. doi: 10.1371/journal.pone.0255769. eCollection 2021. PLoS One. 2021. PMID: 34506503 Free PMC article. Clinical Trial.
Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa.
Okell LC, Kwambai TK, Dhabangi A, Khairallah C, Nkosi-Gondwe T, Winskill P, Opoka R, Mousa A, Kühl MJ, Lucas TCD, Challenger JD, Idro R, Weiss DJ, Cairns M, Ter Kuile FO, Phiri K, Robberstad B, Mori AT. Okell LC, et al. Among authors: nkosi gondwe t. Nat Commun. 2023 Jan 25;14(1):402. doi: 10.1038/s41467-023-35939-w. Nat Commun. 2023. PMID: 36697413 Free PMC article.
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.
Nkosi-Gondwe T, Robberstad B, Opoka R, Kalibbala D, Rujumba J, Galileya LT, Akun P, Nambatya W, Ssenkusu J, TerKuile F, Phiri K, Idro R. Nkosi-Gondwe T, et al. Trials. 2023 Apr 5;24(1):257. doi: 10.1186/s13063-023-07274-4. Trials. 2023. PMID: 37016392 Free PMC article.
Isotopic measurement of iron requirements in sub-Saharan African children.
Speich C, Brittenham GM, Cercamondi CI, Zeder C, Nkosi-Gondwe T, Phiri KS, Moretti D, Zimmermann MB. Speich C, et al. Among authors: nkosi gondwe t. Am J Clin Nutr. 2021 Sep 1;114(3):986-996. doi: 10.1093/ajcn/nqab161. Am J Clin Nutr. 2021. PMID: 34113969 Free article.
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial.
Idro R, Nkosi-Gondwe T, Opoka R, Ssenkusu JM, Dennis K, Tsirizani L, Akun P, Rujumba J, Nambatya W, Kamya C, Phiri N, Joanita K, Komata R, Innussa M, Tenywa E, John CC, Tarning J, Denti P, Wasmann RE, Ter Kuile FO, Robberstad B, Phiri KS. Idro R, et al. Among authors: nkosi gondwe t. Lancet Infect Dis. 2024 Dec 20:S1473-3099(24)00737-0. doi: 10.1016/S1473-3099(24)00737-0. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39718172 Free article.